Landfar(SZ:000504) Sou Hu Cai Jing·2025-04-21 08:24Core Viewpoint - Nanhua Bio's stock closed at 9.01 yuan, down 2.17%, with a latest price-to-book ratio of 11.96 and a total market capitalization of 2.974 billion yuan [1] Financial Performance - For the third quarter of 2024, Nanhua Bio reported operating revenue of 92.4171 million yuan, a year-on-year decrease of 11.78% - The net profit was -8,410,757.01 yuan, reflecting a year-on-year decline of 1828.05% - The sales gross margin stood at 68.03% [1] Market Activity - On April 21, 2024, Nanhua Bio experienced a net outflow of main funds amounting to 6.9602 million yuan, with a total outflow of 8.7643 million yuan over the past five days [1] Business Segments - Nanhua Bio operates in two main sectors: "Biopharmaceuticals" and "Energy Conservation and Environmental Protection" - The "Biopharmaceuticals" segment includes services for the separation, cultivation, and storage of stem cells and immune cells, as well as research on downstream products and clinical applications - The "Energy Conservation and Environmental Protection" segment encompasses energy-saving engineering and product R&D sales, comprehensive sewage treatment for special industries, investment and operation of distributed energy stations, and comprehensive energy-saving project investment and operation [1] Valuation Metrics - Nanhua Bio's PE (TTM) is -80.21, and its static PE is -105.55, with a price-to-book ratio of 11.96, compared to industry averages of 46.70 (TTM PE) and 42.96 (static PE) [2]